| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.25 | 8e-13 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-10 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-07 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.25 | 5e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |